Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Two Generations of Antipsychotics: Applying Lessons from the First Generation of Antipsychotics to Current Treatment Practice

Premiere Date: Tuesday, February 22, 2005
Live Audioconference Series (15 sessions): February - March 2005

This activity offers CE credit for:

1. Physicians (ACCME/AMA PRA Category 1)
2. Nurses (ANCC)
3. Pharmacists (ACPE)
4. Psychologists (APA)
5. Social Workers (NASW)
6. Certified Case Managers (CCMC)

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, March 30, 2007
Note: Credit Is No Longer Available

Faculty

George M. Simpson, MD  Interim Chairman and Professor of Research in Psychiatry Director of the Adult Psychiatric Outpatient Clinic Department of Psychiatry and Behavioral Sciences, CA Keck School of Medicine University of Southern California Los Angeles

Peter J. Weiden, MD  Director, Psychosis Program Center for Cognitive Medicine Department of Psychiatry University of Illinois at Chicago Chicago, IL

Statement of Need

As current treatments for schizophrenia continue to improve, it is helpful to understand their evolution within the framework of earlier generations of treatment. Recognizing the similarities and differences in the issues faced in early trials of conventional antipsychotics compared to the challenges presented by atypical antipsychotics today may offer new insights and linkages to efficacy, safety, and patient choice. In this evidence-based psychCME TALK activity, George Simpson, MD, a pioneer in the development of the first generation of antipsychotics, joins Peter Weiden, MD, to present cutting-edge data surrounding recent advances in the management of schizophrenia while offering a historical context that may provide a better understanding of how clinicians have arrived at their current treatment strategies.

Activity Goal

To utilize lessons learned throughout the development of antipsychotics to gain insights into the efficacy and safety of current atypical antipsychotics.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Provide a historical context of the evolution of antipsychotics that offer insights into the treatment of schizophrenia.
• Examine data comparing the efficacy of atypical antipsychotics in the treatment of positive, negative, and depressive symptoms in patients with schizophrenia.
• Compare and contrast the impact of atypical antipsychotics on metabolic parameters.
• Design a treatment strategy that provides optimal management of symptomatology without exacerbating metabolic disorders.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

CNE Credit (Nurses):
This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV-0450. 1.0 contact hour (Pharmacology)

CEP Credit (Psychologists):
CME Outfitters, LLC, is approved by the American Psychological Association to offer continuing education for psychologists. CME Outfitters, LLC, maintains responsibility for the program. 1.0 CE credits

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.2 contact hours (0.12 CEUs)
Universal Program Number: 376-999-05-004-L01 (live interactive session) 376-999-05-004-H01 (recorded activities)

To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4–6 weeks to all who successfully complete these requirements.

Disclosure Declaration

All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made on this website and within the activity course materials prior to the premiere date of this activity.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).